標題: Titlebook: Clinician’s Manual: Treatment of Hypertension; Third Edition Franz H Messerli Book 2011Latest edition Springer Healthcare Ltd. 2011 Clinica [打印本頁] 作者: intern 時間: 2025-3-21 17:54
書目名稱Clinician’s Manual: Treatment of Hypertension影響因子(影響力)
書目名稱Clinician’s Manual: Treatment of Hypertension影響因子(影響力)學(xué)科排名
書目名稱Clinician’s Manual: Treatment of Hypertension網(wǎng)絡(luò)公開度
書目名稱Clinician’s Manual: Treatment of Hypertension網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Clinician’s Manual: Treatment of Hypertension被引頻次
書目名稱Clinician’s Manual: Treatment of Hypertension被引頻次學(xué)科排名
書目名稱Clinician’s Manual: Treatment of Hypertension年度引用
書目名稱Clinician’s Manual: Treatment of Hypertension年度引用學(xué)科排名
書目名稱Clinician’s Manual: Treatment of Hypertension讀者反饋
書目名稱Clinician’s Manual: Treatment of Hypertension讀者反饋學(xué)科排名
作者: interference 時間: 2025-3-21 22:19
, and timely diagnosis and treatment are essential. .The manual will give the reader a thorough overview of antihypertensive lifestyle modifications, first-line therapy, combination therapies, comorbid conditions, therapeutic challenges, and the latest trends in antihypertensive therapy..Pharmaceutical compan978-1-907673-08-5978-1-907673-32-0作者: Cpap155 時間: 2025-3-22 00:30 作者: Antagonism 時間: 2025-3-22 05:44
The J curve,tolic pressure is critically important for coronary perfusion. Most studies that have examined the relationship between diastolic pressure and the risk of coronary heart disease documented a J-shaped relationship in the physiologic range; namely, diastolic pressures below 85–80 mmHg. In the 22,000-p作者: 嫌惡 時間: 2025-3-22 08:56
Hypertension as a gateway to cardiovascular risk modification,ch strongly favors treatment of the elderly population because age is a more powerful determinant of the short-term risk in the elderly than in younger patients. Additional risk factors that should be considered are diabetes, decreased GFR, proteinuria and cardiac abnormalities on electrocardiograph作者: 松軟無力 時間: 2025-3-22 14:12
To twofer or not to twofer,ardioprotection and to treat hypertension separately by adding another drug class that has been shown to have outcome benefits in hypertension, such as a diuretic, calcium antagonist, or ACE inhibitor. The twofer, however, is perfectly acceptable in the same situation for the ACE inhibitor. ACE inhi作者: 松軟無力 時間: 2025-3-22 20:10
How aggressively should blood pressure be lowered?,iated with two drugs, such as an ARB and a diuretic, or a calcium antagonist and an ACE inhibitor. However, in an elderly, more fragile patient, it is probably justified to start on monotherapy and to uptitrate gradually every 4–6 weeks.作者: 周興旺 時間: 2025-3-22 22:52
Therapeutic challenges,howed a significantly greater reduction of proteinuria with the nondihydropyridine derivatives than with the dihydropyridines in patients with hypertension, regardless of whether or not they had diabetes [80]. However, we should not forget that albuminuria/proteinuria is a surrogate end point that i作者: 門閂 時間: 2025-3-23 03:23 作者: ALERT 時間: 2025-3-23 07:37
Introduction: The Place in the Forest,tolic pressure is critically important for coronary perfusion. Most studies that have examined the relationship between diastolic pressure and the risk of coronary heart disease documented a J-shaped relationship in the physiologic range; namely, diastolic pressures below 85–80 mmHg. In the 22,000-p作者: 熒光 時間: 2025-3-23 09:41
https://doi.org/10.1007/978-1-349-18516-0ch strongly favors treatment of the elderly population because age is a more powerful determinant of the short-term risk in the elderly than in younger patients. Additional risk factors that should be considered are diabetes, decreased GFR, proteinuria and cardiac abnormalities on electrocardiograph作者: 顧客 時間: 2025-3-23 16:28
Introduction: The Place in the Forest,ardioprotection and to treat hypertension separately by adding another drug class that has been shown to have outcome benefits in hypertension, such as a diuretic, calcium antagonist, or ACE inhibitor. The twofer, however, is perfectly acceptable in the same situation for the ACE inhibitor. ACE inhi作者: Felicitous 時間: 2025-3-23 18:50 作者: 享樂主義者 時間: 2025-3-24 02:06
Gemeinsamer Vertreter der Gl?ubigerhowed a significantly greater reduction of proteinuria with the nondihydropyridine derivatives than with the dihydropyridines in patients with hypertension, regardless of whether or not they had diabetes [80]. However, we should not forget that albuminuria/proteinuria is a surrogate end point that i作者: 庇護 時間: 2025-3-24 04:56
Definition of hypertension,ge. It is presently recommended that antihypertensive therapy is started in patients who have “confirmed” hypertension, defined by the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) as a blood pressure (BP) level exce作者: 珠寶 時間: 2025-3-24 06:58
The J curve,as BP is lowered, morbidity and mortality diminish, but, clearly, there is a point at which further lowering leads to the under-perfusion of vital organs and, thereby, will increase morbidity and mortality. Thus, it stands to reason that a J curve has to exist. However, it is not so clear whether th作者: Foregery 時間: 2025-3-24 14:05
Drug therapy or lifestyle modification?,intake to less than 100 mmol/day, modification of alcohol intake to, at most, two drinks per day, and maintenance of an adequate dietary intake of potassium, calcium, and magnesium [2]. The JNC 7 also recommended regular physical activity for all patients with hypertension who have no conditions tha作者: anniversary 時間: 2025-3-24 14:55
Hypertension as a gateway to cardiovascular risk modification,P is clearly inefficient to reduce the overall associated cardiovascular disease risk. Antihypertensive therapy should, therefore, serve as a gateway to overall cardiovascular risk management and give rise to normal risk estimation. This can be done by using the Framingham risk score [1] or the syst作者: Vulnerable 時間: 2025-3-24 23:01 作者: peritonitis 時間: 2025-3-25 02:30
,When initial therapy is insufficient — To uptitrate, to substitute, or to combine?, when BP remains elevated. That physicians are uneasy with this question is illustrated by the fact that patients are often treated for years with the same dose of the same drug or combination, despite the fact that BP is not at goal. Any excuses volunteered by the patient (ie, crowded parking garag作者: AVOID 時間: 2025-3-25 05:19 作者: Dignant 時間: 2025-3-25 11:00 作者: Intend 時間: 2025-3-25 12:27 作者: 含鐵 時間: 2025-3-25 17:19 作者: Texture 時間: 2025-3-25 20:10
Therapeutic challenges,nd slow down the decline in renal function. In type 1 diabetes, most proteinuria studies have used ACE inhibitors, whereas, for type 2 diabetes, ARBs have mostly been used. However, the American Diabetes Association (ADA) have concluded that the evidence was sufficient to state that both drug classe作者: 青春期 時間: 2025-3-26 02:23
Fashions and fads,l nifedipine needed it about as much as a patient with high cholesterol would need a sublingual statin. Of note, there is good evidence that the sublingual application is of no added benefit because what gets into the blood stream is actually what is swallowed. Also, sublingual nifedipine lowers BP 作者: conflate 時間: 2025-3-26 04:46
Gemeinsamer Vertreter der Gl?ubigeron of each drug to the overall outcome in a given patient. Progress has been made in identifying and understanding some drug interactions, allowing the rational combination of certain drugs in a given patient. Drug combinations may be rational for several reasons (Figure 10):作者: 偏狂癥 時間: 2025-3-26 11:37 作者: Chipmunk 時間: 2025-3-26 16:37
https://doi.org/10.37307/b.978-3-503-23631-2eta-blocker, diminishes glucose tolerance and increases the risk of new-onset diabetes. Conversely, as has been revealed in more recent trials, treatment with antihypertensive drugs, such as blockers of the RAS or calcium antagonists, appears to decrease this risk (Figure 25).作者: 表兩個 時間: 2025-3-26 17:20
Comorbid conditions,eta-blocker, diminishes glucose tolerance and increases the risk of new-onset diabetes. Conversely, as has been revealed in more recent trials, treatment with antihypertensive drugs, such as blockers of the RAS or calcium antagonists, appears to decrease this risk (Figure 25).作者: 拍下盜公款 時間: 2025-3-26 21:02 作者: 驚奇 時間: 2025-3-27 04:45
ce..Includes dozens of clear and informative tables and figures to maximize comprehension..Addresses the most recent?and crucial developments in a very common chronic condition..Gives a comprehensive review of currently available medications and combination therapy..Approximately one billion people 作者: capsaicin 時間: 2025-3-27 08:26
Conclusion: The Miscellarian Race, same dose of the same drug or combination, despite the fact that BP is not at goal. Any excuses volunteered by the patient (ie, crowded parking garage, mother-in-law visiting) seem good enough to rationalize that day’s high BP as an exception and delay further therapeutic intervention.作者: 匯總 時間: 2025-3-27 12:52 作者: ablate 時間: 2025-3-27 16:27 作者: prediabetes 時間: 2025-3-27 19:49
Fashions and fads,ngual application is of no added benefit because what gets into the blood stream is actually what is swallowed. Also, sublingual nifedipine lowers BP in a completely uncontrolled way, and such an abrupt BP drop has been associated with acute MI, stroke and death. Clearly, this is BP cosmetics and should be considered malpractice.作者: 違法事實 時間: 2025-3-27 22:32 作者: 財政 時間: 2025-3-28 05:29
Evidence-based versus eminence-based therapy,that out of 100 screened patients with isolated systolic hypertension only one was included in the SHEP study and 99 were excluded for one reason or another. Can the evidence derived from 1% of the population be extrapolated to the remaining 99%?作者: 以煙熏消毒 時間: 2025-3-28 10:14
https://doi.org/10.1007/978-1-907673-32-0Clinical; Professional; Reference; Cardiology作者: incontinence 時間: 2025-3-28 13:15
978-1-907673-08-5Springer Healthcare Ltd. 2011作者: 避開 時間: 2025-3-28 18:00
https://doi.org/10.1007/978-1-349-18516-0By definition, all antihypertensive drugs lower BP. Given at appropriate doses, the antihypertensive efficacy is remarkably similar among various drugs. However, outcome data and adverse effects have been shown to differ from one drug class to another.作者: Ischemic-Stroke 時間: 2025-3-28 21:41 作者: 馬籠頭 時間: 2025-3-28 23:56
Conclusion: The Miscellarian Race,ge. It is presently recommended that antihypertensive therapy is started in patients who have “confirmed” hypertension, defined by the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) as a blood pressure (BP) level exce作者: dry-eye 時間: 2025-3-29 06:58 作者: Biguanides 時間: 2025-3-29 10:32
https://doi.org/10.1007/978-1-349-18516-0intake to less than 100 mmol/day, modification of alcohol intake to, at most, two drinks per day, and maintenance of an adequate dietary intake of potassium, calcium, and magnesium [2]. The JNC 7 also recommended regular physical activity for all patients with hypertension who have no conditions tha作者: jabber 時間: 2025-3-29 14:51
https://doi.org/10.1007/978-1-349-18516-0P is clearly inefficient to reduce the overall associated cardiovascular disease risk. Antihypertensive therapy should, therefore, serve as a gateway to overall cardiovascular risk management and give rise to normal risk estimation. This can be done by using the Framingham risk score [1] or the syst作者: 來就得意 時間: 2025-3-29 17:51
Introduction: The Place in the Forest,tion in adverse effects, the number of pills, and cost. Physicians and patients, therefore, like the “twofer” and use it whenever possible. Unfortunately, the concept of the twofer has never been vigorously tested. Ironclad trials have shown that beta-blockers confer secondary cardioprotection in pa作者: Middle-Ear 時間: 2025-3-29 22:02
Conclusion: The Miscellarian Race, when BP remains elevated. That physicians are uneasy with this question is illustrated by the fact that patients are often treated for years with the same dose of the same drug or combination, despite the fact that BP is not at goal. Any excuses volunteered by the patient (ie, crowded parking garag作者: 被詛咒的人 時間: 2025-3-30 02:17
